miR-21 promotes the fibrotic properties in oral mucosa through targeting PDCD4
Background/purpose: Oral submucous fibrosis (OSF) has been regarded as a premalignant disorder of oral cancer, and myofibroblasts are the main cells that are responsible for pathological fibrosis. Hence, elucidation of the molecular mechanism underlying myofibroblast activation is important to treat...
Saved in:
Main Authors: | Yi-Wen Liao (Author), Lo-Lin Tsai (Author), Yu-Hsien Lee (Author), Pei-Ling Hsieh (Author), Cheng-Chia Yu (Author), Ming-Yi Lu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1
by: Ming-Yi Lu, et al.
Published: (2022) -
Resveratrol inhibits arecoline-induced fibrotic properties of buccal mucosal fibroblasts via miR-200a activation
by: Hui-Wen Yang, et al.
Published: (2024) -
miR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis
by: Jinshan Ye, et al.
Published: (2016) -
Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis
by: Chih-Yuan Fang, et al.
Published: (2022) -
Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin
by: Ran Wang, et al.
Published: (2018)